Effect of Everolimus Treatment on Chromogranin A, Neuron-Specific Enolase, Gastrin, and Glucagon Levels in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET): Phase III RADIANT-3 Study Results.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.10624
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)